Mobile Menu - OpenMobile Menu - Closed


Health Care


In the 113th Congressman Bilirakis joined the Energy and Commerce Committee. Part of his Committee assignment includes serving on the Health Subcommittee, with jurisdiction over Medicare, Medicaid, the Affordable Care Act – better known as Obamacare – and the rest of the American health care system.

Congressman Bilirakis has introduced two pieces of legislation to help preserve Medicare for current and future beneficiaries. H.R. 3392, the Medicare Part D Patient Safety and Drug Abuse Prevention Act, would establish a Safe Pharmacy Access Program, to prevent high-risk beneficiaries from abusing controlled substances. This is a cost-saving measure utilized by private industry, TRICARE, and state Medicaid programs. H.R. 2828, the Medicare Abuse Prevention (MAP) Act, would remove Social Security Numbers from Medicare cards and strengthens the civil and criminal penalties for Medicare, Medicaid, and CHIP abuse. It would also incentivize states to conduct their own prescription drug monitoring programs.

Bilirakis is a staunch opponent of Obamacare. He opposed the legislation when it passed in 2009, and has worked to repeal and replace the law. Bilirakis supports the infusion of free market principles and cost transparency into the health care system, which he believes is the best way to lower costs and increase access to affordable care. He opposed a government takeover of health care, and has long been an advocate for Health Savings Accounts, access to catastrophic care, and high risk pools to ensure coverage for individuals with pre-existing conditions.

Bilirakis supports legislation to allow veterans who completed military emergency medical technician (EMT) training to more easily receive civilian accreditation to work as EMTs; to create a 10-Year Pediatric Research Initiative Fund to the National Institutes of Health; and to allow epi-pens to be kept in schools. In the past, Bilirakis has sponsored legislation to require Medicare to cover hearing aids for older Americans to improve their quality of life and increase their safety. Gus also has voted to renew important breast and cervical cancer detection programs.

Additionally, Congressman Bilirakis is a member of numerous health care-related caucuses through which he advocates for many important causes, including the:

  • Community Health Center Caucus
  • Brain Injury Task Force
  • Health Care Caucus;
  • Prescription Drug Caucus;
  • Congenital Heart Caucus;
  • Cystic Fibrosis Caucus;
  • Diabetes Caucus;
  • Down Syndrome Caucus;
  • Health Hearing Caucus;
  • Vision Caucus;
  • House Cancer Caucus; and
  • Pediatric Cancer Caucus.

More on Health Care

June 20, 2017 Page

The 21st Century Cures Act has been three years in the making, and on December 13, 2016, it was finally signed into law. Over the years, Rep. Bilirakis has met with local patients, doctors, and advocates from Florida to discuss how to get new treatments and cures to market faster. Proudly, much of their input is reflected in the final law.

June 7, 2017 Press Release

Washington, D.C. – U.S. Rep. Gus Bilirakis (FL-12), a member of the House Energy and Commerce Committee, applauded the committee’s passage of legislation today to reform the Food & Drug Administration (FDA) and promote important public health priorities. Among the bills advanced today are Bilirakis’ Congenital Heart Futures Reauthorization Act (H.R. 1222) and the FDA Reauthorization Act (H.R.

May 31, 2017 Press Release
U.S. Rep. Gus Bilirakis (FL-12) applauded today new efforts to combat the nation’s opioid crisis with over $70 million in grant funding to help communities and health care providers prevent overdose and treat addiction.
May 23, 2017 Press Release
As the summer months heat up in Florida, U.S. Rep. Gus Bilirakis (FL-12) renewed the call for an improved, coordinated approach to combating the Zika virus.
May 18, 2017 Press Release
Today, U.S. Rep. Gus Bilirakis (FL-12) applauded progress made on legislation he championed to lower the price of prescription medication, and reauthorize research programs for congenital heart disease and sickle cell disease.
May 16, 2017 Bilirakis Blog
In my district in Florida and across the country, Many of us in Congress continue to hear from our constituents about Americans continue to feel the pressure of rising health care costsprescription drug costs. Too often, bad actors in the marketplace take advantage of monopolies, skyrocketing the price of lifesaving medication simply because there is little to no competition.
May 4, 2017 Press Release
U.S. Rep. Gus Bilirakis (FL-12) released the following statement on the American Health Care Act (H.R. 1628).
April 28, 2017 Press Release
U.S. Rep. Gus Bilirakis (FL-12) announced his support for legislation to prevent Members of Congress from exempting themselves and their staff from the American Health Care Act (AHCA).
April 20, 2017 Press Release
U.S. Rep. Gus Bilirakis (FL-12) announced today Florida will receive over $27 million in grants to help fight the opioid epidemic, the first of two rounds of funding secured by Bilirakis in the 21st Century Cures Act.
March 29, 2017 Press Release
U.S. Rep. Gus Bilirakis (FL-12), a member of the Energy and Commerce Subcommittee on Health, today released the following statement after President Trump took executive action to convene a commission that will review ways to combat the nation’s opioid crisis and better assist those affected.